The physicochemical nature of eosinophil chemotactic factor (ECF) was examined by using different maturation stages of eosinophils, namely eosinophils obtained from bone marrow (BM-Eo) and those obtained from peritoneal cavity (PEC-Eo), as the indicator of in vitro chemotaxis. As the ECF source, the conditioned medium of the culture of spleen cells obtained from Schistosoma japonicum-infectedmice was used. When the conditioned medium was chromatographed by Sephadex G75, apparent molecular weight of ECF activity against BM-Eo was 15,000, whereas that against PEC-Eo was 30,000. Similar results were obtained when the conditioned medium was chromatographed by high-pressure liquid chromatography using SW3000 column. After NaCl-linear gradient elution of DE52 anion-exchange chromatography of the conditioned medium, ECF activity against PEC-Eo was detected at the 0.1 M NaCl region of the gradient, whereas that against BM-Eo was detected at around the 0.14 M NaCl region. After isoelectric focusing, however, ECF activity against BM-Eo and PEC-Eo was detected at the same position, approximately pH 3.6. The results of surface phenotype analysis show that the cells responsible for the production of two types of ECF lymphokines are both Thy-1.2+, Lyt-1.2––, Lyt-2.2+. When ECF activity in the conditioned medium of antigen-specific T cell clones was examined, 6 out of 7 clones produce ECF lymphokine relatively selective to PEC-Eo, whereas one clone produce ECF lymphokine relatively selective to BM-Eo. These results suggest that physicochemically different ECF lymphokines selective to different maturation stages of eosinophils are involved in the mediation of eosinophilia.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.